Sign inJoin waitlistJoin the waitlist

Sara Helmig

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
University of Texas Southwestern Medical Center
2011–2014
Internal Medicine
University of Texas Southwestern Medical Center
2008–2011
Tulane University School of Medicine, New Orleans, Louisiana
2004–2008
University Notre Dame, South Bend Indiana

Research

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
Journal of Clinical Oncology · 2022 · 89 citations
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
Clinical Cancer Research · 2019 · 74 citations
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
European Journal of Cancer · 2020 · 64 citations

Alberto Pappo
7 papers
Sara Federico
7 papers
Michael Bishop
6 papers
Anthony Sheyn
5 papers
Barry Shulkin
5 papers
Jessica Gartrell
4 papers
Matthew Krasin
4 papers
Wayne Furman
4 papers
Andrew Davidoff
3 papers
Brandon Triplett
3 papers
Elizabeth Stewart
3 papers
Fariba Navid
3 papers

Clinical trials

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Site PI · Recruiting · Phase 2
Children's Hospital of Philadelphia
2024–2031
Project: Every Child for Younger Patients With Cancer
Site PI · Recruiting
Children's Oncology Group
2015–2030